novel
coronaviru
sever
acut
respiratori
syndrom
coronaviru
emerg
six
human
coronavirus
four
common
human
coronavirus
caus
mild
moder
upper
respiratori
tract
ill
includ
alpha
coronaviru
alpha
coronaviru
beta
coronaviru
beta
coronaviru
first
record
two
human
coronavirus
sarscov
merscov
lead
sever
lung
infect
known
sever
acut
respiratori
syndrom
sar
middl
east
respiratori
syndrom
mer
respect
sarscov
outbreak
occur
start
china
spread
countri
death
rate
merscov
outbreak
occur
start
saudi
arabia
spread
countri
death
rate
see
outbreak
affect
upper
respiratori
lower
respiratori
tract
caus
unusu
viral
pneumonia
name
coronaviru
diseas
covid
novel
coronavirusinfect
pneumonia
ncip
three
coronavirus
caus
human
pandem
beta
coronavirus
antivir
immun
includ
innat
immun
adapt
immun
respons
two
main
varieti
innat
immun
receptor
transmembran
cytosol
critic
establish
innat
immun
respons
therebi
lead
adapt
immun
respons
transmembran
receptor
mainli
tolllik
receptor
tlr
sens
live
dead
virus
capac
cytosol
innat
immun
receptor
includ
rigilik
receptor
rlr
nodlik
receptor
nlr
receptor
alr
limit
sens
live
virus
consist
among
differ
innat
immun
receptor
tlr
close
relat
adapt
immun
respons
tlr
therefor
import
element
antivir
immun
detect
complet
infecti
viral
particl
includ
viral
nucleic
acid
viral
envelop
protein
defect
viral
particl
upon
recognit
viru
tlr
signal
upregul
express
proinflammatori
cytokin
costimulatori
molecul
accumul
interferon
ifn
consequ
adapt
antimicrobi
immun
process
costimulatori
molecul
date
experi
proven
innat
immun
receptor
undertak
detect
sarscov
patient
sever
sarscov
infect
show
aberr
innat
immun
system
particular
induct
proinflammatori
cytokin
type
ifn
interferonstimul
gene
isg
would
undergo
oscil
clearli
favor
sarscov
releas
proinflammatori
cytokin
chemokin
occur
first
day
infect
high
level
proinflammatori
cytokin
patient
sarscov
diseas
correl
acut
respiratori
distress
syndrom
age
anim
upregul
type
ifn
isg
observ
two
day
infect
studi
show
ifn
defici
exacerb
sarscov
diseas
anim
treatment
type
ifn
could
help
control
sarscov
replic
therefor
possibl
suppos
innat
immun
mechan
essenti
role
immun
sarscov
microparasit
live
organ
smaller
parasit
reproduc
singl
host
therebi
result
hostmedi
immun
respons
macroparasit
bigger
multipl
host
involv
cytokin
chemokin
initi
elong
phase
diseas
initi
stage
would
increas
plasma
concentr
differ
cytokin
includ
basic
fgf
gcsf
gmcsf
pdgf
vascular
endotheli
growth
factor
critic
ill
patient
admit
intens
care
unit
icu
show
higher
level
gcsf
compar
need
icu
work
seem
interplay
differ
thelper
th
cell
popul
subset
eg
treg
instanc
microparasit
macroparasit
correl
orchestr
immun
respons
mycobacterium
tuberculosi
prototyp
microparasit
link
three
treg
cell
expans
among
patient
present
primari
care
clinic
symptom
ill
preval
dyspnea
acut
respiratori
distress
syndrom
median
day
ill
onset
requir
icu
median
day
ill
onset
studi
patient
infect
reveal
abnorm
plasma
content
biochem
immun
paramet
note
blood
abnorm
includ
hypoalbuminemia
low
number
lymphocyt
low
percent
neutrophil
high
level
lactat
dehydrogenas
ldh
angiotensin
ii
creactiv
protein
crp
associ
sever
lung
injuri
case
viral
respiratori
infect
process
immun
system
continu
recogn
viral
particl
seek
elimin
infect
cell
take
place
difficulti
partli
respiratori
tract
extens
mucos
surfac
area
exposur
environ
everyth
favor
microbi
colon
surveil
partli
natur
viru
pathogen
bacteria
power
attach
mucos
surfac
interact
respiratori
epithelium
liabl
superinfect
occur
spanish
flu
pandem
henc
would
understand
presenc
viru
increas
bacteri
adher
interfer
epithelium
barrier
integr
induc
product
adhes
protein
viral
factor
downregul
function
immun
cell
destroy
equilibrium
respiratori
system
besid
respiratori
system
coronavirus
tend
affect
nervou
system
gastrointestin
system
anim
evid
transmit
anim
human
zoonot
diseas
three
coronavirus
sarscov
merscov
correl
aggress
form
diseas
transmiss
human
occur
directli
indirectli
mainli
occur
direct
transmiss
respiratori
droplet
indirect
transmiss
happen
touch
surfac
contamin
viru
less
possibl
sourc
spread
spread
clinic
latenc
stage
therefor
classic
model
epidem
outbreak
appli
particular
case
also
averag
reproduct
number
indic
averag
number
secondari
case
increas
offici
data
estim
averag
clinic
latenc
stage
last
day
longer
median
incub
period
day
day
thu
promis
point
treatment
symptomat
individu
use
howev
mention
reproduct
number
vari
time
depend
estim
model
averag
reproduct
number
estim
stochast
method
mathemat
method
articl
highlight
trace
epidemiolog
charact
provid
understand
immun
diseas
elderli
popul
increas
risk
develop
die
comorbid
present
case
infect
men
time
like
die
transmiss
influenc
hostrel
factor
eg
age
male
gender
comorbid
condit
known
associ
immun
dysregul
first
ultim
pictur
lung
injuri
accompani
storm
proinflammatori
cytokin
exponenti
growth
respect
moreov
simul
method
predict
continu
effort
wuhan
would
achiev
reproduct
number
less
one
soon
frame
immunogenet
explan
epidemiolog
dynam
wuhan
condit
first
appear
experienc
worst
drought
year
last
year
addit
decemb
first
recogn
first
month
winter
time
place
outbreak
sarscov
occur
precis
condit
winter
season
low
humid
therefor
understand
relat
origin
chang
condit
climat
winter
low
humid
act
stressor
immun
system
evid
indic
associ
cold
temperatur
low
humid
respiratori
tract
infect
manner
lower
environment
temperaturehumid
sooner
respiratori
tract
infect
occur
popul
earli
interferongamma
induct
viral
infect
indic
battl
innat
immun
viru
colder
temperatur
product
rigilik
receptor
rlr
essenti
recognit
viral
rna
innat
immun
decreas
airway
cell
well
adapt
viral
replic
immun
system
would
commenc
fever
allow
express
trigger
seri
antivir
immun
respons
character
product
cytokin
nearli
report
common
symptom
infect
onset
fever
impact
hostrel
factor
age
gender
physiolog
health
evid
transmiss
well
elderli
popul
increas
risk
develop
die
mean
age
peopl
year
age
could
strongli
predict
fate
diseas
becam
youngest
patient
sever
contrast
children
adolesc
least
like
group
infect
occur
patient
year
age
younger
even
get
sick
get
mild
form
diseas
without
seriou
complic
averag
probabl
die
studi
infant
infect
report
fever
mild
upper
respiratori
tract
symptom
symptom
viru
one
remark
featur
antivir
immun
show
adapt
strategi
stage
human
life
innat
immun
cell
born
capabl
make
regulatori
cell
cytokin
helper
cell
cytokin
incap
induct
helper
cell
cytokin
type
interferon
divers
tcell
receptor
tcr
repertoir
decreas
age
new
lineag
oligoclon
cell
express
natur
killer
nk
relat
receptor
nkr
form
taken
togeth
realtim
data
infect
addit
experiment
evid
regard
immunolog
featur
promin
neonat
children
adult
seem
import
immunomodulatori
cytokin
exagger
immun
moreov
age
condit
associ
inflamm
wherea
neonat
period
relat
immatur
antiinflammatori
respons
consid
proinflammatori
respons
initi
sarscov
infect
logic
possibl
overwhelm
inflammatori
reaction
age
subject
support
old
anim
sarscov
infect
show
high
level
proinflammatori
cytokin
conjointli
sign
symptom
respiratori
failur
men
constitut
twothird
report
case
vs
also
men
time
like
die
death
rate
vs
gener
sexual
differ
play
import
role
affect
immun
system
function
therefor
drive
variabl
respons
infect
particular
men
gener
thought
produc
lesser
amount
type
ifn
inflammatori
cytokin
possess
lower
number
circul
cell
expect
requir
defens
virus
defici
men
compar
women
distinct
antivir
immun
men
women
exist
due
genet
factor
environment
factor
hormon
factor
comorbid
present
case
except
less
total
chronic
condit
found
case
die
arrang
relat
mortal
rate
chronic
condit
victim
viru
includ
cardiovascular
diseas
diabet
chronic
respiratori
diseas
hypertens
cancer
condit
longterm
tend
make
immun
system
imperfect
innat
adapt
immun
function
reninangiotensin
system
ra
detect
sever
tissu
serv
hormon
system
contribut
regul
blood
pressur
gener
autocrin
paracrin
signal
ra
key
player
angiotensinconvert
enzym
implic
cardiovascular
diseas
mediat
inflamm
bind
receptor
therefor
might
expect
pose
signific
threat
patient
alreadi
problem
ra
would
partli
process
inflamm
take
place
infect
occur
virus
famili
coronavirida
vari
remark
degre
becom
genet
mutat
though
share
genet
mutabl
recombin
mechan
errorpron
replicationa
fundament
mechan
genom
variat
virul
use
mechan
sarscov
becam
mutat
increas
virul
wherea
merscov
chang
significantli
discoveri
former
bind
angiotensinconvert
enzym
latter
receptor
receptor
appear
cellular
receptor
well
result
mild
moder
lung
diseas
taken
togeth
bind
receptor
would
necessarili
pertain
behavior
sarscov
pathogen
diseas
seem
associ
transmiss
term
reproduct
number
less
sever
diseas
overal
case
fatal
rate
march
reproduct
number
greater
one
would
probabl
exhibit
trend
similar
phylogenet
analysi
indic
common
ancestor
human
human
sarscov
bat
sarscov
converg
addit
four
structur
viral
protein
spike
membran
nucleocapsid
n
envelop
e
impli
high
degre
share
ident
rang
human
bat
coronavirus
support
view
human
descend
anim
acquir
differ
mark
protein
tcell
epitop
receptorbind
motif
undergon
modif
sarscov
enter
cell
waythrough
bind
present
lung
gastrointestin
epithelia
howev
poor
conserv
receptorbind
motif
known
structur
protein
spike
sarscov
indic
new
protein
undergon
modif
compar
spike
gene
marin
coronaviru
bat
coronaviru
spike
gene
human
vari
differ
point
due
synonym
mutat
nonsynonym
substitut
varieti
partli
explain
human
adopt
new
structur
becom
fit
attach
human
cell
howev
novel
coronaviru
exhibit
distinct
pattern
tcell
epitop
particular
tcell
epitop
mainli
engag
antivir
immun
appear
mutat
frequent
tcell
epitop
merscov
sarscov
lifethreaten
live
challeng
epidemiolog
immunolog
current
evid
point
effect
novel
coronaviru
inhibit
antivir
immun
respons
therefor
power
capac
replic
host
cell
hand
shown
highest
incid
rate
mortal
rate
elderli
popul
peopl
certain
comorbid
known
differ
immun
profil
review
conclud
trace
epidemiolog
charact
viru
provid
understand
immun
diseas
help
prevent
treatment
diseas
vulner
individu
specif
drug
exist
howev
patient
given
varieti
medicin
supplement
improv
immun
respons
includ
metformin
glitazon
fibrat
sartan
atorvastin
also
long
list
less
safe
better
choic
term
antivir
immun
provid
patient
eg
cyclosporin
lopinavirritonavir
interferon
beta
ribavirin
monoclon
antibodi
antivir
peptid
vitro
studi
test
effect
seven
drug
infect
rate
report
chloroquin
antimalari
agent
remdesivir
antiebola
drug
effect
inhibit
infect
strengthen
evid
remdesivir
success
prevent
control
merscovinduc
clinic
diseas
nonhuman
primat
angiotensinconvert
enzym
inhibitor
acei
angiotensin
receptor
blocker
arb
appar
requir
normal
abnorm
high
level
angiotensin
ii
patient
howev
consensu
yet
reach
use
acei
arb
patient
challeng
wherea
isol
host
grown
host
cell
anim
model
diseas
judg
condit
caus
proposit
need
test
anim
model
diseas
human
use
doubt
futur
line
research
devot
develop
vaccin
activ
immun
viral
genom
structur
protein
direct
tendenc
impair
immun
surveil
analysi
protein
sequenc
shown
eight
hladr
epitop
locat
spike
envelop
membran
play
essenti
part
obstruct
immun
surveil
also
bcell
cytotox
lymphocyt
epitop
uniqu
present
surfac
glycoprotein
epitop
like
vaccin
target
superinfect
apathogen
dsrna
viru
strengthen
upregul
ifn
key
player
antivir
immun
could
shown
method
call
superinfect
therapeut
sit
strategi
promot
resolut
viral
infect
dna
rna
virus
howev
determin
whether
would
confer
benefit
case
well
anoth
era
treatment
infect
devot
clinic
develop
tcell
product
first
ultim
pictur
lung
injuri
accompani
storm
proinflammatori
cytokin
howev
use
antiinflammatori
drug
eg
corticosteroid
advers
sideeffect
importantli
demonstr
avalab
studi
effect
clinic
endpoint
seem
standard
antivir
agent
plu
support
care
find
immun
biomark
distinguish
severetocrit
mildtomoder
infect
would
help
design
target
immunotherapi
paper
fund
author
relev
affili
financi
involv
organ
entiti
financi
interest
financi
conflict
subject
matter
materi
discuss
manuscript
includ
employ
consult
honoraria
stock
ownership
option
expert
testimoni
grant
patent
receiv
pend
royalti
peer
review
manuscript
relev
financi
relationship
disclos
